Vitreomacular Traction
15
1
1
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
6.7%
1 terminated out of 15 trials
90.9%
+4.4% vs benchmark
20%
3 trials in Phase 3/4
40%
4 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (15)
UNITY VCS Vitreoretinal Surgery
Zeiss RESIGHT Disposable Lenses Evaluation Study
Vitreopapillary Interface and Optic Disc Morphology
Methotrexate Infusion and Intrasilicone Injection During Diabetic Vitrectomy
Ocular Coherence Tomography During Cataract Assessment
Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery
Effects of Pneumatic Vitreolysis on Vitreomacular Traction
Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains
Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists)
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion
Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study
Assessment of Patients Treated With JETREA® for Vitreomacular Traction
A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment
A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)
Comparison of Two Techniques for Epiretinal or Internal Limiting Membrane Peel